Hudson Bay Capital Management’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,359,246
| Closed | -$815K | – | 747 |
|
|
2024
Q3 | $815K | Sell |
1,359,246
-1,038,522
| -43% | -$623K | ﹤0.01% | 505 |
|
|
2024
Q2 | $6.47M | Buy |
2,397,768
+886,867
| +59% | +$2.39M | 0.03% | 259 |
|
|
2024
Q1 | $7.75M | Buy |
1,510,901
+964,607
| +177% | +$4.95M | 0.04% | 177 |
|
|
2023
Q4 | $293K | Hold |
546,294
| – | – | ﹤0.01% | 492 |
|
|
2023
Q3 | $362K | Hold |
546,294
| – | – | ﹤0.01% | 528 |
|
|
2023
Q2 | $830K | Buy |
+546,294
| New | +$830K | 0.01% | 539 |
|
|
2021
Q3 | – | Sell |
-80,000
| Closed | -$1.09M | – | 985 |
|
|
2021
Q2 | $1.09M | Buy |
+80,000
| New | +$1.09M | 0.01% | 696 |
|